Recombinant insulin-like growth factor-1 improves cardiac function and symptoms in the patients on the waiting list for heart transplantation with end-stage dilated cardiomyopathy
Event:
ESC CONGRESS 2017
Topic:
Drug therapy
Session:
Inflammation, diabetes and their influence on the heart
Anticholinergic bronchodilator improves both pulmonary and cardiac functions in patients with heart failure with reduced ejection fraction complicated with chronic obstructive pulmonary disease.
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
